Decrease of the incidence of human and canine visceral leishmaniasis after dog vaccination with Leishmune in Brazilian endemic areas
- PMID: 19464528
- DOI: 10.1016/j.vaccine.2009.03.045
Decrease of the incidence of human and canine visceral leishmaniasis after dog vaccination with Leishmune in Brazilian endemic areas
Abstract
Leishmune, the first prophylactic vaccine licensed against canine visceral leishmaniasis (CVL), has been used in Brazil since 2004, where seropositive dogs are sacrificed in order to control human visceral leishmaniasis (VL). We demonstrate here that vaccination with Leishmune does not interfere with the serological control campaign (110,000 dogs). Only 1.3% of positivity (76 among 5860) was detected among Leishmune uninfected vaccinees. We also analyzed the possible additive effect of Leishmune vaccination over dog culling, on the decrease of the incidence of CVL and VL in two Brazilian endemic areas, from 2004 to 2006. In Araçatuba, a 25% of decline was seen in CVL with a 61% decline in human cases, indicating the additive effect of Leishmune vaccination of 5.7% of the healthy dogs (1419 dogs), on regular dog culling. In Belo Horizonte (BH), rising curves of canine and human incidence were observed in the districts of Barreiro, Venda Nova and Noroeste, while the canine and human incidence of Centro Sul, Leste, Nordeste, Norte, Pampulha and Oeste, started to decrease or maintained a stabilized plateau after Leishmune vaccination. Among the districts showing a percent decrease of human incidence (-36.5%), Centro Sul and Pampulha showed the highest dog vaccination percents (63.27% and 27.27%, respectively) and the lowest dog incidence (-3.36% and 1.89%, respectively). They were followed by Oeste, that vaccinated 25.30% of the animals and experienced an increase of only 12.86% of dog incidence and by Leste and Nordeste, with lower proportions of vaccinees (11.72% and 10.76%, respectively) and probably because of that, slightly higher canine incidences (42.77% and 35.73%). The only exception was found in Norte district where the reduced human and canine incidence were not correlated to Leishmune vaccination. Much lower proportions of dogs were vaccinated in Venda Nova (4.35%), Noroeste (10.27%) and Barreiro (0.09%) districts, which according to that exhibited very increased canine incidences (24.48%, 21.85% and 328.57%, respectively), and pronounced increases in human incidence (14%, 4% and 17%, respectively). The decrease of canine (p=-0.008) and human incidences (p=-0.048) is directly correlated to the increase of the number of vaccinated dogs, confirming the additive control effect of Leishmune vaccination over dog culling, reducing the parasite reservoir, protecting dogs and, in this way, reducing the risk of transmission of VL to humans and becoming a new effective control tool.
Similar articles
-
Longitudinal analysis of serological tests officially adopted by the Brazilian Ministry of Health for the diagnosis of canine visceral leishmaniasis in dogs vaccinated with Leishmune®.Vet Parasitol. 2013 Nov 8;197(3-4):649-52. doi: 10.1016/j.vetpar.2013.07.013. Epub 2013 Jul 18. Vet Parasitol. 2013. PMID: 23920056
-
Diminished CD4+/CD25+ T cell and increased IFN-gamma levels occur in dogs vaccinated with Leishmune in an endemic area for visceral leishmaniasis.Vet Immunol Immunopathol. 2010 Jun 15;135(3-4):296-302. doi: 10.1016/j.vetimm.2009.12.008. Epub 2010 Jan 21. Vet Immunol Immunopathol. 2010. PMID: 20132994
-
Leishmune vaccine blocks the transmission of canine visceral leishmaniasis: absence of Leishmania parasites in blood, skin and lymph nodes of vaccinated exposed dogs.Vaccine. 2005 Sep 23;23(40):4805-10. doi: 10.1016/j.vaccine.2005.05.011. Vaccine. 2005. PMID: 16011864
-
Leishmune vaccine: the newest tool for prevention and control of canine visceral leishmaniosis and its potential as a transmission-blocking vaccine.Vet Parasitol. 2006 Oct 10;141(1-2):1-8. doi: 10.1016/j.vetpar.2006.05.001. Epub 2006 Jun 5. Vet Parasitol. 2006. PMID: 16750885 Review.
-
Canine leishmaniasis.Adv Parasitol. 2004;57:1-88. doi: 10.1016/S0065-308X(04)57001-X. Adv Parasitol. 2004. PMID: 15504537 Review.
Cited by
-
Translating Observations From Leishmanization Into Non-Living Vaccines: The Potential of Dendritic Cell-Based Vaccination Strategies Against Leishmania.Front Immunol. 2018 Jun 4;9:1227. doi: 10.3389/fimmu.2018.01227. eCollection 2018. Front Immunol. 2018. PMID: 29922288 Free PMC article. Review.
-
Advances toward Diagnostic Tools for Managing Zoonotic Visceral Leishmaniasis.Trends Parasitol. 2018 Oct;34(10):881-890. doi: 10.1016/j.pt.2018.07.012. Epub 2018 Aug 18. Trends Parasitol. 2018. PMID: 30131210 Free PMC article. Review.
-
Nonconventional opponents: a review of malaria and leishmaniasis among United States Armed Forces.PeerJ. 2019 Jan 25;7:e6313. doi: 10.7717/peerj.6313. eCollection 2019. PeerJ. 2019. PMID: 30701136 Free PMC article.
-
Methods of Control of the Leishmania infantum Dog Reservoir: State of the Art.Vet Med Int. 2011;2011:215964. doi: 10.4061/2011/215964. Epub 2011 Jul 7. Vet Med Int. 2011. PMID: 21772963 Free PMC article.
-
NH36 and F3 Antigen-Primed Dendritic Cells Show Preserved Migrating Capabilities and CCR7 Expression and F3 Is Effective in Immunotherapy of Visceral Leishmaniasis.Front Immunol. 2018 May 7;9:967. doi: 10.3389/fimmu.2018.00967. eCollection 2018. Front Immunol. 2018. PMID: 29867949 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical